128,907 Shares in Select Medical Holdings Corporation $SEM Purchased by Penn Capital Management Company LLC

Penn Capital Management Company LLC purchased a new position in Select Medical Holdings Corporation (NYSE:SEM) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 128,907 shares of the health services provider’s stock, valued at approximately $1,914,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP raised its position in Select Medical by 4.2% in the third quarter. Dimensional Fund Advisors LP now owns 5,197,343 shares of the health services provider’s stock worth $66,731,000 after purchasing an additional 207,951 shares in the last quarter. State Street Corp grew its stake in Select Medical by 1.3% during the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after buying an additional 55,686 shares during the last quarter. Western Standard LLC grew its stake in Select Medical by 95.6% during the fourth quarter. Western Standard LLC now owns 2,064,021 shares of the health services provider’s stock worth $30,651,000 after buying an additional 1,008,664 shares during the last quarter. 8 Knots Management LLC bought a new stake in Select Medical during the second quarter worth about $26,568,000. Finally, Bank of America Corp DE grew its stake in Select Medical by 3.4% during the third quarter. Bank of America Corp DE now owns 1,673,302 shares of the health services provider’s stock worth $21,485,000 after buying an additional 54,640 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Price Performance

SEM opened at $16.53 on Wednesday. Select Medical Holdings Corporation has a one year low of $11.65 and a one year high of $16.99. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15. The company’s 50 day simple moving average is $16.40 and its 200-day simple moving average is $15.54. The stock has a market capitalization of $2.05 billion, a P/E ratio of 15.59, a price-to-earnings-growth ratio of 0.95 and a beta of 1.02.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same period last year, the company earned $0.44 earnings per share. Select Medical’s revenue for the quarter was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

Select Medical announced that its board has approved a stock buyback plan on Thursday, February 19th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to repurchase up to 49.5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th will be paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 14th. Select Medical’s dividend payout ratio is 23.58%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on SEM shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Select Medical in a research note on Wednesday, May 20th. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $16.50 price objective (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Zacks Research raised shares of Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Finally, Wall Street Zen cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $15.50.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.